These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21094867)

  • 1. Liver transplantation for metastasized extragastrointestinal stromal tumor: a case report and an overview of literature.
    Frilling A; Malago M; Testa G; Schleyer E; Grabellus F; Kronenberger R; Li J; Broelsch CE
    Transplant Proc; 2010 Nov; 42(9):3843-8. PubMed ID: 21094867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall.
    Lam MM; Corless CL; Goldblum JR; Heinrich MC; Downs-Kelly E; Rubin BP
    Int J Gynecol Pathol; 2006 Jul; 25(3):288-92. PubMed ID: 16810068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extragastrointestinal stromal tumor arising in the rectovaginal septum: report of an unusual case with literature review.
    Zhang W; Peng Z; Xu L
    Gynecol Oncol; 2009 Jun; 113(3):399-401. PubMed ID: 19297012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term survival after surgery and adjuvant imatinib in a patient with rectal GIST, local recurrence, liver metastases and mediastinal pleural metastasis].
    Tsutsui M; Yoshino S; Sakamoto K; Oka M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2351-3. PubMed ID: 20037419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal stromal tumor presenting as a rectovaginal mass. Clinicopathologic and molecular-genetic characterization of a rare tumor with a literature review.
    Pelz AF; Agaimy A; Daniels M; Evert M; Schulz HU; Lüders P; Müller G; Lasota J; Röpke A; Wieacker P; Miettinen M; Schneider-Stock R
    Hum Pathol; 2011 Apr; 42(4):586-93. PubMed ID: 21237497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Curative resection for bulky rectal gastrointestinal stromal tumor after neoadjuvant imatinib mesylate].
    Kobayashi H; Uetake H; Higuchi T; Enomoto M; Yasuno M; Iida S; Yoshimura T; Ishikawa T; Ishiguro M; Kato S; Ono H; Kikuchi A; Yamauchi S; Sugihara K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2620-2. PubMed ID: 21224658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A successfully resected case of liver metastasis of gastrointestinal stromal tumor responding to neoadjuvant chemotherapy with imatinib mesylate and interventional radiology].
    Tamura J; Nakayama Y; Kitaguchi K; Ura K; Taira K; Ooe H; Yoshikawa A; Ishigami S; Baba N
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1769-72. PubMed ID: 19838046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
    Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
    Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal stromal tumor arising in the rectovaginal septum.
    Vázquez J; Pérez-Peña M; González B; Sánchez A
    J Low Genit Tract Dis; 2012 Apr; 16(2):158-61. PubMed ID: 22371045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extragastrointestinal stromal tumor and liver transplantation: case report and review.
    Camargo MA; Boin I; Mainnardi JP; de Lourdes M; Ayrizono S; Coy CS; Leonardi MI; Meirelles L; Leonardi LS; Escanhoela CA
    Transplant Proc; 2008 Dec; 40(10):3781-3. PubMed ID: 19100489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib mesylate treatment for advanced gastrointestinal stromal tumor: a pilot study focusing on patients experiencing sole liver metastasis after a prior radical resection.
    Zhu J; Wang Y; Hou M; Li HY; Zhang J
    Oncology; 2007; 73(5-6):324-7. PubMed ID: 18497504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival after living-donor liver transplantation for unresectable colorectal metastases to the liver: case report.
    Kocman B; Mikulić D; Jadrijevic S; Poljak M; Kocman I; Gašparov S; Kanižaj TF; Cvrlje VČ
    Transplant Proc; 2011 Dec; 43(10):4013-5. PubMed ID: 22172891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A long-term survival case with multiple liver metastases from duodenal gastrointestinal stromal tumor that was drastically reduced by the treatment with imatinib].
    Sakakura C; Miyagawa K; Fukuda K; Kin S; Nakase Y; Kuriu Y; Nakashima S; Yoshikawa T; Yamaoka N; Sagara Y; Hagiwara A; Yamagishi H
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1739-41. PubMed ID: 16315926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living donor liver transplantation for unresectable liver metastases from solid pseudo-papillary tumor of the pancreas: a case report.
    Kocman B; Jadrijević S; Skopljanac A; Mikulić D; Gustin D; Buhin M; Matasić H; Gasparov S; Suknaić S; Ivanović D
    Transplant Proc; 2008 Dec; 40(10):3787-90. PubMed ID: 19100491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study.
    Pappas P; Karavasilis V; Briasoulis E; Pavlidis N; Marselos M
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):358-60. PubMed ID: 15883819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Imatinib mesylate alone for refractory advanced gastrointestinal stromal tumor].
    Shen L; Jin ML
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):697-9. PubMed ID: 15777512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of imatinib mesylate in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy with epirubicin.
    Fiorentini G; Bernardeschi P; De Simone M; Rossi S; Dentico P; Biancalani M; Scuderi S; Vaira M; Palomba A
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):13-6. PubMed ID: 16767899
    [No Abstract]   [Full Text] [Related]  

  • 18. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of low-dose and long-term administration of imatinib in patients with liver metastases of rectal GIST and GIST of stomach].
    Kimura O; Yamamoto O; Hisamitsu K; Yamane N; Hamazoe R
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2285-7. PubMed ID: 21224549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.